LONGEVITY.TECHNOLOGY

Junevity emerges with $10m to ‘reset’ cells to a healthy state

Startup aims to restore key transcription factors with siRNA therapeutics to reverse cellular dysfunction and combat age-related diseases.

Previous
Previous

FIRSTWORD PHARMA

Next
Next

PRESS RELEASE